Company Profile
Identity and Values
Meet Avalon through the identity, vision, mission, values and pillars that guide its work.
Company Profile
Who We Are
Middle East Pharmaceutical Industries Company (Avalon Pharma), hereinafter referred to as the “Company” or “Avalon,” was established in Riyadh, Kingdom of Saudi Arabia, on 2 Rabi’ Al-Thani 1419 AH, corresponding to 26 July 1998, as a limited liability company under Commercial Registration No. 1010150538. Avalon converted into a joint-stock company on 13 Ramadan 1443 AH, corresponding to 14 April 2022, and its shares were listed on the Saudi Stock Exchange (Tadawul) on 16 Sha’ban 1445 AH, corresponding to 26 February 2024, under the trading symbol 4016. Avalon’s paid-up capital amounted to 200 million, distributed across 20 million fully paid shares, with a nominal value of 10 per share.
Our Vision
Avalon aspires to be a leading name in the fields of health, beauty, and wellness by strengthening its presence as an innovative, customer-focused organization that contributes to creating a positive and sustainable impact in communities around the world.
Our Mission
Avalon seeks to develop, manufacture, and market a wide range of leading products in the fields of health and beauty, in addition to prescription generic pharmaceuticals, to ensure the delivery of high-quality therapeutic solutions to the markets of the Kingdom of Saudi Arabia, the Middle East and North Africa, Eastern Europe, Asia, and Africa.
Avalon DNA
Our Values
Recognition
We value and uphold the trust placed in us by our customers, patients, stakeholders, and regulatory authorities.
Learning
We are committed to the continuous development of professional skills and behaviors to implement best practices across all levels of the Company and enhance our positive impact on society.
Care
Through mutual support and collaboration, we prioritize the health and well-being of our customers and patients, At the same time, we adapt to change and respond with agility to the needs of our stakeholders and the markets in which we operate.
Ambition
Driven by our vision to lead in the pharmaceutical sector, we are committed to delivering products of high standards that align with the rapid developments in the market.
Resilience
We operate efficiently and swiftly, with integrated coordination across all aspects of our operations to ensure optimal performance.
Optimism
We are committed to enhancing the health and well-being of the communities we serve In the markets where we operate, continuously striving to achieve the highest standards of excellence in healthcare.
Company Profile
Core Pillars of Excellence
- 01
Innovative Talents
We develop a business model based on leveraging internal and external talents, while continuously enhancing capabilities and skills.
- 02
Commercial Excellence
We focus on driving demand and enhancing customer satisfaction to ensure sustainable growth in the markets.
- 03
Geographical Expansion
We rely on a well-planned growth strategy that targets the right markets while selecting the appropriate business model and portfolio for each market.
- 04
Operational Sustainability
We achieve sustainability by implementing a robust strategy focused on long-term trans formative solutions.
- 05
Strategic Partnerships
We establish our position as a distinguished strategic partner through our flexible approach, offering innovative collaboration models that align with the needs of our partners and the community.